Centricity Vision announced new ZEPTOLink enhancements, reducing treatment time by up to 60%. These updates, aimed at ...

Bausch + Lomb receives US FDA approval for enVista Envy full range of vision intraocular lens: Vaughan, Ontario Tuesday, October 15, 2024, 17:00 Hrs [IST] Bausch + Lomb Corporatio ...

The Lopez-led Asian Eye Institute announced Monday that two of its most accomplished doctors were recognized by top ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has ...

A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global Intraocular Lens (IOL) market ...

Archaeologists have unearthed a secret tomb in front of the Treasury – an elaborate 2,000 year-old mausoleum carved into a ...

According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...

Bausch + Lomb said enVista Envy intraocular lenses will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. The company is in the process of seeking ...

Over and above, 66 suspects were arrested in CIT related cases, making a combined number of 115 arrests for CIT and related ...

Most people over age 60 eventually get cataracts. This common condition typically starts very slowly, so those who don’t have regular eye exams may not realize what’s going on inside their eyes.

If you're thinking about getting cataract surgery, here's what a renowned ophthalmologist says you should know.

Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at ...